Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-17-000114
Filing Date
2017-05-19
Accepted
2017-05-19 16:54:20
Documents
27
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 sangui10q_20170331vedgar4.htm 10-Q 254657
2 exhibit3101.htm EX-31 8507
3 exhibit3102.htm EX-31 9068
4 exhibit3201.htm EX-32 4211
  Complete submission text file 0001551163-17-000114.txt   843118

Data Files

Seq Description Document Type Size
5 sgbi-20170331.xml EX-101.INS 59261
6 sgbi-20170331.xsd EX-101.SCH 7641
7 sgbi-20170331_cal.xml EX-101.CAL 15418
8 sgbi-20170331_def.xml EX-101.DEF 5376
9 sgbi-20170331_lab.xml EX-101.LAB 72299
10 sgbi-20170331_pre.xml EX-101.PRE 54033
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

EIN.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 17858597
SIC: 2834 Pharmaceutical Preparations